Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats
Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-11
DOI: 10.2147/dddt.s570825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Riyadh S Almalki. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Cannabinoids, Pulmonary Fibrosis, Amiodarone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
ORCID-Profile: Riyadh S Almalki
Zitieren
APA
Almalki, R. S. (2026). Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats. Drug Design, Development and Therapy, Volume 20, 1-11. https://doi.org/10.2147/dddt.s570825
Vancouver
Almalki RS. Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats. Drug Design, Development and Therapy. 2026;Volume 20:1-11. doi:10.2147/dddt.s570825
BibTeX
@article{Almalki2026,
author = {Almalki, Riyadh S},
title = {Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--11},
doi = {10.2147/dddt.s570825}
}
EUVIMED